| 727 - 729 |
Introduction: Metals in Medicine
Franz KJ, Metzler-Nolte N |
| 730 - 796 |
Metal Compounds against Neglected Tropical Diseases
Ong YC, Roy S, Andrews PC, Gasser G |
| 797 - 828 |
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
Monro S, Colon KL, Yin HM, Roque J, Konda P, Gujar S, Thummel RP, Lilge L, Cameron CG, McFarland SA |
| 829 - 869 |
Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs
Soldevila-Barreda JJ, Metzler-Nolte N |
| 870 - 901 |
Radioactive Transition Metals for Imaging and Therapy
Boros E, Packard AB |
| 902 - 956 |
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik TI, Orvig C |
| 957 - 1057 |
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner J, Gale EM, Rodriguez-Rodriguez A, Caravan P |
| 1058 - 1137 |
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Kenny RG, Marmion CJ |
| 1138 - 1192 |
Stimuli-Responsive Therapeutic Metallodrugs
Wang XH, Wang XY, Jin SX, Muhammad N, Guo ZJ |
| 1193 - 1220 |
Iron Acquisition in Mycobacterium tuberculosis
Chao A, Sieminski PJ, Owens CP, Goulding CW |
| 1221 - 1322 |
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Savelieff MG, Nam G, Kang J, Lee HJ, Lee M, Lim MH |
| 1323 - 1455 |
Targeting Metalloenzymes for Therapeutic Intervention
Chen AY, Adamek RN, Dick BL, Credille CV, Morrison CN, Cohen SM |
| 1456 - 1518 |
Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics
Markwalter CF, Kantor AG, Moore CP, Richardson KA, Wright DW |
| 1519 - 1624 |
Metal Drugs and the Anticancer Immune Response
Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W |
